24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Reports
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:05
EU would view Israel “in the same category as China” if judicial reforms go through
13:26
This is fine? Wake up and smell the smoke!
12:18
“To some extent I am spite driven. I got so pissed at the situation and thought this has to change”
11:05
Is 2023 the year of “CMO-as-a-Service”?
More stories
Buzz
Most popular
Daily
Weekly
1
Cybersecurity company Cyren on verge of shut down after laying off entire workforce
2
Meet Israel’s most diverse tech company
3
EU would view Israel “in the same category as China” if judicial reforms go through
4
Israeli nuclear fusion startup raises $22 million Series A for clean energy solution
5
Full list of Israeli high-tech funding rounds in 2023
More news
Reports
11 stories about Reports
Despite record $2.1 billion in H1 sales, IAI faces 5 major challenges
10.08.20
|
Udi Etsion
Israel's largest state-owned defence contractor had a successful first half in 2020, but it seems unlikely to repeat these results any time soon
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO
19.02.20
|
Sophie Shulman
Teva’s stock fluctuation is not the result of wrongdoing regarding the U.S. opioid abuse epidemic, but rather something born of the creativity of lawyers, Kåre Schultz said Wednesday at the company’s annual press conference in Tel Aviv
IFF's Frutarom Dream Hits Reality, Hard
17.02.20
|
Sophie Shulman
A little over a year after IFF's $6.4 billion acquisition of Israel-based Frutarom, its annual results for 2019 fail to deliver desired boost in sales
Teva’s Small Print Gives Rise to Optimism
13.02.20
|
Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
Barclays Sees Potential Upside in Nice Stock Following Second-Quarter Reports
13.08.18
|
CTech
On Thursday, Israel-headquartered Nice reported GAAP revenues of $342 million, a 10% increase year-over-year, bolstered by a 28% year-over-year increase in cloud revenues
Weakness in the Mobile Sector Drags Down Tower Semiconductor’s Quarterly Profits
26.07.18
|
Hezi Sternlicht
On Thursday, the company reported net profits of $38 million, up 45% from the first quarter of the year but down 24% compared to the second quarter of 2017
Mellanox Upgrades Outlook Following Record Quarterly Revenues
18.07.18
|
Dror Reich
In June, Mellanox's board settled its differences with activist investor Starboard, which has been aggressively pushing for far-reaching changes since November
Arms Race is On, Says Arms Manufacturer
21.03.18
|
Hezi Sternlicht
Israel-based defense contractor Elbit has seen an 11% increase in backlog in 2017 compared to 2016, largely driven by a worldwide increase in defense budgets
More Money, Fewer Deals: Five Key Takeaways from Cisco's 2017 Report on Investment in Israeli Startups
15.02.18
|
Daniel Karp
Israeli startups in 2017 raised 13% more capital compared with the year before, but saw 9% fewer deals
Berkshire Hathaway Takes Position in Generic Drugmaker Teva
15.02.18
|
Lilach Baumer
The holding company disclosed a $358 million stake in the struggling company
Teva’s Perfect Storm Sends Tel-Aviv Stock Exchange Down
06.08.17
|
Calcalist
Teva’s stock price dropped sharply on Thursday and Friday after the company released quarterly revenue and profits that fell short of analysts’ forecasts
